Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy

References

• Chang L, Ernst T, Speck O, Grob C S. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry 2005; 162: 361–369
   PubMed Web of Science ®Google Scholar
• Chang L, Ernst T, Witt M D, Ames N, Gaiefsky M, Miller E. Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naive HIV patients. Neuroimage 2002; 17: 1638–1648
   PubMed Web of Science ®Google Scholar
• Chang L, Ernst T, Witt M D, Ames N, Walot I, Jovicich J, De Silva M, Trivedi N, Speck O, Miller E N. Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART. Antiviral Ther 2003; 8: 17–26
   PubMed Web of Science ®Google Scholar
• Chang L, Lee P L, Yiannoutsos C T, Ernst T, Marra C M, Richards T, Kolson D, Schifitto G, Jarvik J G, Miller E N, Lenkinski R, Gonzalez G, Navia B A. A multicenter in vivo proton-MRS study of HIV−associated dementia and its relationship to age. Neuroimage 2004; 23: 1336–1347
   PubMed Web of Science ®Google Scholar
• Chong W K, Paley M, Wilkinson I D, Hall-Craggs M A, Sweeney B, Harrison M J, Miller R F, Kendall B E. Localized cerebral proton MR spectroscopy in HIV infection and AIDS. AJNR Am J Neuroradiol 1994; 15: 21–25
   Google Scholar
• Chong W K, Sweeney B, Wilkinson I D, Paley M, Hall-Craggs M A, Kendall B E, Shepard J K, Beecham M, Miller R F, Weller I V, et al. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology 1993; 188: 119–124
   PubMed Web of Science ®Google Scholar
• Cohen J, Cohen P. Applied multiple regression/correlation analysis for the behavioral sciences. Lawrence Erlbaum, Hillsdale, NJ 1983
   Google Scholar
• Davidson C, Gow A J, Lee T H, Ellinwood E H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Brain Res Rev 2001; 36: 1–22
   PubMed Web of Science ®Google Scholar
• Demougeot C, Garnier P, Mossiat C, Bertrand N, Giroud M, Beley A, Marie C. N-acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J Neurochem 2001; 77: 408–415
   Google Scholar
• Eisch A J, O'Dell S J, Marshall J F. Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of methamphetamine. Synapse 1996; 22: 217–225
   Google Scholar
• Ellis R J, Childers M E, Cherner M, Lazzaretto D, Letendre S, Grant I. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis 2003; 188: 1820–1826
   PubMed Web of Science ®Google Scholar
• Ernst T, Chang L, Leonido-Yee M, Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 2000; 54: 1344–1349
   PubMed Web of Science ®Google Scholar
• Everall I, Salaria S, Roberts E, Corbeil J, Sasik R, Fox H, Grant I, Masliah E. Methamphetamine stimulates interferon inducible genes in HIV infected brain. J Neuroimmunol 2005; 170: 158–171
   Google Scholar
• First M B, Spitzer R L, Gibbon M, Williams J B. Structured clinical interview for DSM-IV Axis I disorders. Biometrics Research Department, New York 1996
   Google Scholar
• Flora G, Lee Y W, Nath A, Hennig B, Maragos W, Toborek M. Methamphetamine potentiates HIV−1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain. Exp Neurol 2003; 179: 60–70
   PubMed Web of Science ®Google Scholar
• Itoh K, Mehraein P, Weis S. Neuronal damage of the substantia nigra in HIV−1 infected brains. Acta Neuropathol (Berl) 2000; 99: 376–384
   PubMed Web of Science ®Google Scholar
• Jarvik J G, Lenkinski R E, Grossman R I, Gomori J M, Schnall M D, Frank I. Proton MR spectroscopy of HIV−infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology 1993; 186: 739–744
   PubMed Web of Science ®Google Scholar
• Jernigan T L, Gamst A C, Archibald S L, Fennema-Notestine C, Mindt M R, Marcotte T D, Heaton R K, Ellis R J, Grant I. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry 2005; 162: 1461–1472
   PubMed Web of Science ®Google Scholar
• Langford D, Adame A, Grigorian A, Grant I, McCutchan J A, Ellis R J, Marcotte T D, Masliah E. Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J Acquir Immune Defic Syndr 2003; 34: 467–474
   PubMed Web of Science ®Google Scholar
• Laubenberger J, Haussinger D, Bayer S, Thielemann S, Schneider B, Mundinger A, Hennig J, Langer M. HIV−related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology 1996; 199: 805–810
   PubMed Web of Science ®Google Scholar
• Lee P L, Yiannoutsos C T, Ernst T, Chang L, Marra C M, Jarvik J G, Richards T L, Kwok E W, Kolson D L, Simpson D, Tang C Y, Schifitto G, Ketonen L M, Meyerhoff D J, Lenkinski R E, Gonzalez R G, Navia B A. A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis. J Magn Reson Imaging 2003; 17: 625–633
   PubMed Web of Science ®Google Scholar
• Lopez-Villegas D, Lenkinski R E, Frank I. Biochemical changes in the frontal lobe of HIV−infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci USA 1997; 94: 9854–9859
   PubMed Web of Science ®Google Scholar
• Maragos W F, Young K L, Turchan J T, Guseva M, Pauly J R, Nath A, Cass W A. Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. J Neurochem 2002; 83: 955–963
   PubMedGoogle Scholar
• Marshall J F, O'Dell S J, Weihmuller F B. Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity. J Neural Transm Gen Sect 1993; 91: 241–254
   Google Scholar
• McLean M A, Woermann F G, Barker G J, Duncan J S. Quantitative analysis of short echo time (1)H-MRSI of cerebral gray and white matter. Magn Reson Med 2000; 44: 401–411
   PubMedGoogle Scholar
• Meyerhoff D J, Weiner M W, Fein G. Deep gray matter structures in HIV infection: a proton MR spectroscopic study. AJNR Am J Neuroradiol 1996; 17: 973–978
   Google Scholar
• Moller H E, Vermathen P, Lentschig M G, Schuierer G, Schwarz S, Wiedermann D, Evers S, Husstedt I W. Metabolic characterization of AIDS dementia complex by spectroscopic imaging. J Magn Reson Imaging 1999; 9: 10–18
   PubMed Web of Science ®Google Scholar
• Nordahl T E, Salo R, Natsuaki Y, Galloway G P, Waters C, Moore C D, Kile S, Buonocore M H. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 2005; 62: 444–452
   PubMed Web of Science ®Google Scholar
• Nordahl T E, Salo R, Possin K, Gibson D R, Flynn N, Leamon M, Galloway G P, Pfefferbaum A, Spielman D M, Adalsteinsson E, Sullivan E V. Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy. Psychiatry Res 2002; 116: 43–52
   PubMed Web of Science ®Google Scholar
• Ohmori T, Abekawa T, Koyama T. The role of glutamate in behavioral and neurotoxic effects of methamphetamine. Neurochem Int 1996; 29: 301–307
   Google Scholar
• Paley M, Cozzone P J, Alonso J, Vion-Dury J, Confort-Gouny S, Wilkinson I D, Chong W K, Hall-Craggs M A, Harrison M J, Gili J, Rovira A, Capellades J, Rio J, Ocana I, Nicoli F, Dhiver C, Gastaut J L, Gastaut J A, Wicklow K, Sauter R. A multicenter proton magnetic resonance spectroscopy study of neurological complications of AIDS. AIDS Res Hum Retroviruses 1996; 12: 213–222
   Google Scholar
• Provencher S W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672–679
   PubMed Web of Science ®Google Scholar
• Reyes M G, Faraldi F, Senseng C S, Flowers C, Fariello R. Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol (Berl) 1991; 82: 39–44
   PubMed Web of Science ®Google Scholar
• Rippeth J D, Heaton R K, Carey C L, Marcotte T D, Moore D J, Gonzalez R, Wolfson T, Grant I. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 2004; 10: 1–14
   PubMed Web of Science ®Google Scholar
• Robinson T E, Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 1997; 17: 8491–8497
   PubMed Web of Science ®Google Scholar
• Robinson T E, Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci 1999; 11: 1598–1604
   PubMed Web of Science ®Google Scholar
• Schweinsburg B C, Taylor M J, Alhassoon O M, Videen J S, Brown G G, Patterson T L, Berger F, Grant I. Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury. Alcohol Clin Exp Res 2001; 25: 924–934
   PubMedGoogle Scholar
• Schweinsburg B C, Taylor M J, Videen J S, Alhassoon O M, Patterson T L, Grant I. Elevated myo-inositol in gray matter of recently detoxified but not long-term abstinent alcoholics: a preliminary MR spectroscopy study. Alcohol Clin Exp Res 2000; 24: 699–705
   Google Scholar
• Sekine Y, Minabe Y, Kawai M, Suzuki K, Iyo M, Isoda H, Sakahara H, Ashby C R, Jr, Takei N, Mori N. Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms. A proton MRS study. Neuropsychopharmacology 2002; 27: 453–461
   Google Scholar
• Simon S L, Richardson K, Dacey J, Glynn S, Domier C P, Rawson R A, Ling W. A comparison of patterns of methamphetamine and cocaine use. J Addict Dis 2002; 21: 35–44
   PubMed Web of Science ®Google Scholar
• Soher B J, Hurd R E, Sailasuta N, Barker P B. Quantitation of automated single-voxel proton MRS using cerebral water as an internal reference. Magn Reson Med 1996; 36: 335–339
   PubMed Web of Science ®Google Scholar
• Stankoff B, Tourbah A, Suarez S, Turell E, Stievenart J L, Payan C, Coutellier A, Herson S, Baril L, Bricaire F, Calvez V, Cabanis E A, Lacomblez L, Lubetzki C. Clinical and spectroscopic improvement in HIV−associated cognitive impairment. Neurology 2001; 56: 112–115
   PubMed Web of Science ®Google Scholar
• Stephans S E, Yamamoto B K. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse 1994; 17: 203–209
   PubMed Web of Science ®Google Scholar
• Suwanwelaa N, Phanuphak P, Phanthumchinda K, Suwanwela N C, Tantivatana J, Ruxrungtham K, Suttipan J, Wangsuphachart S, Hanvanich M. Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV−infected patients. Magn Reson Imaging 2000; 18: 859–865
   Google Scholar
• Tarasow E, Wiercinska-Drapalo A, Kubas B, Dzienis W, Orzechowska-Bobkiewicz A, Prokopowicz D, Walecki J. Cerebral MR spectroscopy in neurologically asymptomatic HIV−infected patients. Acta Radiol 2003; 44: 206–212
   Google Scholar
• Taylor M J, Alhassoon O M, Schweinsburg B C, Videen J S, Grant I. MR spectroscopy in HIV and stimulant dependence HNRC Group. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 2000; 6: 83–85
   PubMed Web of Science ®Google Scholar
• Theodore S, Cass W A, Nath A, Steiner J, Young K, Maragos W F. Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction. Neurobiol Dis 2006; 23: 663–668
   Google Scholar
• Tracey I, Carr C A, Guimaraes A R, Worth J L, Navia B A, Gonzalez R G. Brain choline-containing compounds are elevated in HIV−positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study. Neurology 1996; 46: 783–788
   Google Scholar
• von Giesen H J, Wittsack H J, Wenserski F, Koller H, Hefter H, Arendt G. Basal ganglia metabolite abnormalities in minor motor disorders associated with human immunodeficiency virus type 1. Arch Neurol 2001; 58: 1281–1286
   Google Scholar
• Wilkinson I D, Miller R F, Miszkiel K A, Paley M N, Hall-Craggs M A, Baldeweg T, Williams I G, Carter S, Newman S P, Kendall B E, Catalan J, Chinn R J, Harrison M J. Cerebral proton magnetic resonance spectroscopy in asymptomatic HIV infection. AIDS 1997; 11: 289–295
   Google Scholar
• Wilson J M, Kalasinsky K S, Levey A I, Bergeron C, Reiber G, Anthony R M, Schmunk G A, Shannak K, Haycock J W, Kish S J. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 1996; 2: 699–703
   PubMed Web of Science ®Google Scholar
• Yiannoutsos C T, Ernst T, Chang L, Lee P L, Richards T, Marra C M, Meyerhoff D J, Jarvik J G, Kolson D, Schifitto G, Ellis R J, Swindells S, Simpson D M, Miller E N, Gonzalez R G, Navia B A. Regional patterns of brain metabolites in AIDS dementia complex. Neuroimage 2004; 23: 928–935
   PubMed Web of Science ®Google Scholar